Linda Baddour, Chief Financial Officer at PHARMACEUTICAL PRODUCT DEVELOPMENT INC (PPDI), sold 15,000 shares at $69.79 ($1.0M) on 2006-02-24, disclosed to the SEC on 2006-02-27.
Open-market sale of $1.0M PPDI by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $69.62 | 200 | $14K | 1.3% |
| 2 | $69.63 | 10,200 | $710K | 68.0% |
| 3 | $69.64 | 200 | $14K | 1.3% |
| 4 | $69.65 | 100 | $7K | 0.7% |
| 5 | $69.66 | 100 | $7K | 0.7% |
| 6 | $69.70 | 16 |
| $1K |
| 0.1% |
| 7 | $69.71 | 1,100 | $77K | 7.3% |
| 8 | $69.72 | 100 | $7K | 0.7% |
| 9 | $69.73 | 400 | $28K | 2.7% |
| 10 | $69.74 | 500 | $35K | 3.3% |
| 11 | $69.75 | 600 | $42K | 4.0% |
| 12 | $69.76 | 32 | $2K | 0.2% |
| 13 | $69.78 | 600 | $42K | 4.0% |
| 14 | $69.79 | 852 | $59K | 5.7% |
| Total | $69.66 avg | 15,000 | $1.0M | 100% |
| Filing → |
| WAT | SELL | 2021-05-14 | $787K | — | Filing → |
| PRAH | SELL | 2018-01-18 | $12.1M | — | Filing → |
| PRAH | SELL | 2017-08-16 | $15.0M | — | Filing → |